From Rory........... Thank you Roni. I fully expected to

New Post Public Reply Private Reply Replies (5) Message Board
Roni1 Natural Treasures #8440
737
From Rory...........

Thank you Roni. I fully expected to take a lot of heat for the back-up strategy around the reverse split and I acknowledge that a RS appears to contradict directly my prior comments about doing a RS. It does. And I intend to own that and explain my thinking in Monday’s SHAC video, which thinking incorporates the benefit of some of the greatest business minds with whom I’ve consulted on these issues, all of whom are nFusz shareholders, Board members and Advisory Board members, and all of whom, as shareholders, have their interests aligned with yours and all other shareholders. And most importantly – all of whom, including me and my team, bear the same consequences of our decisions that you do. So, none of our decisions are made lightly. Quite the contrary. We have one goal. Just one. Increase shareholder value. Everything we do must ultimately contribute to that goal. And every decision we make is made with that goal in mind. That doesn’t mean that shareholder value and corresponding stock price is a straight up arrow. There will be ups and downs, peaks and valleys, and accumulation opportunities along the way for those with vision. For many, especially OTC day traders, it’s impossible to see the forest through the trees. Some because they don’t see the long-term vision being executed, some because they don’t understand it, and others because they are sheep easily scared out of their shares by people whose interests are not aligned with theirs, and in some cases, as we now know, by people who don’t even own the stock and are paid to scare people out of their shares by unsavory characters who make a living preying on others in violation of the law. This is the unfortunate side of the OTC. I do not mean to disparage the many companies who trade on the OTC that have honest, legitimate thriving businesses or those working towards those goals, or the OTC investors who play by the rules and look for quality long-term investments. But I’m committed to building a multi-billion-dollar business. I know that in order to do that, we need to create partnerships with major industry players which we’re doing, continue to revise, revamp and improve the product design, architecture, features and functionality, which we’re doing; identify, pursue, negotiate and close accretive, complementary acquisitions, which we’re doing, and ensure that large institutional investors that appreciate the value creation opportunity nFusz represents and who subscribe to our long-term vision, can invest in our company, which means we must be trading on NASDAQ or NYSE. That’s not negotiable. Most people today are unable to purchase our shares through their existing brokerage accounts because those firms will not fulfill their orders for an OTC share traded company. That’s a fact. For that reason alone we need to uplist to NASDAQ. But it’s not the only reason. I’ve said from the very beginning, we are not an OTC company and but for the way we started, we would not have been an OTC company. We would have been a venture-backed tech company getting ready for a NASDAQ or NYSE IPO and the average investor would have never had an opportunity to participate in our stock. Many see this as an opportunity, others don’t or are easily swayed by the noise. The things we’ve done and the things we’re doing are hard. Very hard. But that’s why we’re doing them. We leave the easy things to others. We thrive on hard; we thrive on achieving those things others say can’t be done. And we take pride in making them a reality – our reality. The reality we’re creating for ourselves, our families and our shareholders. This is how it’s done. No one is going to hand it to us; we’ve got to go take it, and some will try to make it even harder than it is. But we’ve been here before, we’ve done this before. And we’re going to do it again. Sure, nothing in life is guaranteed, but we’re putting our own money behind this, along with yours, and we believe in ourselves and those who stand with us, behind us, and along-side us. I never said the path would be without challenges; we’re working through some today. What I have said is that when we come together, we can accomplish those things others perceive as impossible. And together we’ll weather storms and celebrate the wins. Always together.

Rory

TON Strategy Co. (TONX) Stock Research Links

TONX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Isar’s Nova Scotia Pad Build Gives MAXQ a Real Test

Updated Category News Views 137

Concrete work is where space ambition stops being a brochure. Isar Aerospace has taken operational responsibility for its dedicated launch infrastructure at Spaceport Nova Scotia, and construction is beginning on the Canadian launch pad it will use. For Maritime Launch Services, this is the sort of update that deserves more than the usual starry-eyed applause. A Site...

Continue Reading
Ajman Memory Gives Heritage a Durable Digital Backbone

Updated Category News Views 21

Archives usually get applause only after somebody realizes a piece of history has vanished. Ajman is trying to skip that miserable part. During the Ajman Media Forum 2026, held November 18 and 19 at the Emirates Hospitality Centre, the emirate launched Ajman Memory, a project built to collect, document and preserve photographs, papers and video recording its development....

Continue Reading
Employer Ghosting Is a Quiet Talent-Cost Problem Today

Updated Category News Views 184

Silence is cheap right up until a company needs talent again. Then the unanswered email, abandoned interview loop, or vanished promise of next steps comes back with a price tag—maybe not neatly labeled in a quarterly filing, but real all the same. LiveCareer’s April 14, 2026 survey of 1,008 employed U.S. adults lands on an uncomfortable point: candidates remember...

Continue Reading
Anthropic's Leveraged ETFs Arrive After Wild Debut

Updated Category News Views 319

Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...

Continue Reading
Fluence Investors Face a November 27 Litigation Clock

Updated Category News Views 168

Six calendar squares are all that separate eligible Fluence investors from the November 27, 2026 lead-plaintiff deadline. That is not much time to locate trade confirmations, calculate losses, and decide whether taking a larger role in a securities case makes sense. The lawsuit is not a verdict, and anybody pretending otherwise is selling smoke. But the underlying...

Continue Reading
Persistent Dry Eye Symptoms Call for a Closer Look

Updated Category News Views 114

Eyes can turn into a stubborn little nuisance long before people realize something more complicated is going on. A bottle of artificial tears is easy to grab, cheap enough, and often perfectly sensible for a rough day of screens, wind, reading, or air conditioning. But Dr. Harlan Snyder’s point is the one worth sitting with: when dryness keeps barging back despite...

Continue Reading
3TREES Tests a Bigger Asia-Pacific Growth Blueprint

Updated Category News Views 196

A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...

Continue Reading
Fractional CIOs Bring Order to Growing Technology Chaos

Updated Category News Views 142

A company can outgrow its technology habits long before anyone notices the smoke. One day the owner is approving another software subscription, the office manager is chasing an internet provider, and the tech person is putting out password fires. None of that looks dramatic in isolation. Together, it is a business operating without a map. That is the useful point in the...

Continue Reading
Alibaba Lawsuit Deadline Puts Disclosure Risk in Focus

Updated Category News Views 191

A calendar deadline is doing more work than any earnings headline for Alibaba shareholders this week. A securities class action notice says investors who bought or acquired Alibaba Group Holding Limited securities between May 23, 2024 and November 11, 2026 may seek appointment as lead plaintiff by January 19, 2027. That is a procedural milestone, not a verdict, and...

Continue Reading
Domino's Probe Puts Franchise Disclosure Under Lens

Updated Category News Views 139

A franchisee's shuttered stores can turn cheerful unit-growth talk into a nasty accounting of credibility, and that is the uncomfortable territory Domino's now occupies. Kahn Swick & Foti has opened an investigation into whether Domino's officers and directors breached fiduciary duties or violated state or federal law. That is not a finding of misconduct. It is a legal...

Continue Reading

Top 5 Most Recently Viewed Articles

Ryan Specialty Group's Strategic Push with Innovisk Acquisition

Updated Category News Views 151

Ryan Specialty Group's Acquisition Strategy Ryan Specialty Group (NYSE: RYAN), a prominent player in the specialty insurance sector, is on the brink of finalizing its acquisition of Innovisk Capital Partners. This move is primarily aimed at bolstering their underwriting capacity and expanding their overall market presence. The anticipated completion of the transaction is...

Continue Reading
Stifel Adjusts Align Technology Target Amid Restructuring Plans

Updated Category News Views 216

Stifel Adjusts Align Technology Target Price Recently, Stifel revised its outlook on Align Technology (NASDAQ: ALGN), lowering the price target from $285 to $275 while maintaining a Buy rating on the stock. This adjustment reflects the company's third-quarter financial performance, which met the expectations outlined in the analyst's prior survey. Performance Overview The...

Continue Reading
Golf Scramble Fundraiser to Empower Chicago's Youth Programs

Updated Category News Views 161

Golf Scramble Fundraiser to Empower Youth Nonprofit organization buildOn is excited to announce its inaugural Drive for Students Golf Scramble, a unique fundraiser focused on uniting students through service and education. This event is dedicated primarily to empowering young individuals and providing them the necessary tools to make a lasting impact in their communities....

Continue Reading
Key Highlights from Last Year's Most Notable Releases

Updated Category News Views 255

Overview of Press Releases That Made an Impact The past year was filled with significant announcements and updates that captured audience interest across various sectors. From recalls to growth strategies, the stories represented a multitude of companies and their evolving narratives. Top Press Releases of the Year Some highlights from the most widely read releases over...

Continue Reading
Thomas 'Biz Doc' Ellsworth Joins the Private Economic Council

Updated Category News Views 173

Thomas 'Biz Doc' Ellsworth Joins the Private Economic Council The Private Economic Council (PEC), a coalition of prominent economists, entrepreneurs, and policy makers, has welcomed Thomas Ellsworth to its influential roster. This news highlights Ellsworth's perceived value amidst a team dedicated to fostering economic growth. Experience and Background Ellsworth, known as...

Continue Reading